Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial Post author:admin Post published:March 10, 2025 Post category:uncategorized Post comments:0 Comments Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. You Might Also Like AI identifies new high-risk subtype in endometrial cancer June 28, 2024 Cellular competition determines X chromosome usage in female bodies July 26, 2024 Needle pain is a big problem for kids. One California doctor has a plan. March 20, 2024 Leave a Reply Cancel replyYou must be logged in to post a comment.